An in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: Material properties and drug release kinetics

Journal of Biomedical Materials Research - Part A

Volumn 95, Issue 3 A, 2010, Pages 857-869

  Owen, Gethin Rh ^a   Jackson, John K ^a   Chehroudi, Babak ^a   Brunette, Donald M ^a   Burt, Helen M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Di block copolymer; Drug release; Guided tissue regeneration membrane; Methoxypoly(ethyleneglycol); Poly(lactic co glycolic acid)

Indexed keywords

ANTI-INFLAMMATORY AGENTS; BARRIER MEMBRANE; CELL MORPHOLOGY; CONCENTRATION-DEPENDENT; CONTROLLED RELEASE SYSTEMS; DI-BLOCK COPOLYMER; DIBLOCKS; DRUG LOADING; DRUG RELEASE; DRUG RELEASE KINETICS; GUIDED TISSUE REGENERATION; HYDROCHLORIDE SALTS; IN-VITRO; MATERIAL PROPERTY; MEMBRANE PERFORMANCE; PERIODONTAL LIGAMENT CELLS; POLY(D , L-LACTIC ACID); POLY(LACTIC-CO-GLYCOLIC ACID); RELEASE PROFILES; RELEASE RATE; ROOT SURFACES; SOLVENT EVAPORATION; STRESS-STRAIN; SURGICAL OUTCOME; SUSTAINED RELEASE;

BLOCK COPOLYMERS; COPOLYMERIZATION; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACTIC ACID; LIGAMENTS; MORPHOLOGY; ORGANIC POLYMERS; PLASTIC FILMS; POLYETHYLENES;

MEMBRANES;

MACROGOL DERIVATIVE; METHOXYPOLY(ETHYLENEGLYCOL); POLYGLACTIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRUCTURE; DRUG SOLUBILITY; ELASTICITY; EXPLANT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; PERIODONTAL LIGAMENT; STRESS STRAIN RELATIONSHIP; SUSTAINED DRUG RELEASE; TISSUE REGENERATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOCOMPATIBLE MATERIALS; CELLS, CULTURED; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ELASTICITY; GUIDED TISSUE REGENERATION, PERIODONTAL; LACTIC ACID; MATERIALS TESTING; PERIODONTAL LIGAMENT; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; STRESS, MECHANICAL; SWINE; TETRACYCLINE;

EID: 78249234371     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32865     Document Type: Article

References (67)

1. Listgarten MA,. Pathogenesis of periodontitis. J Clin Periodontol 1986; 13: 418 -430.
2. Sbordone L, Bortolaia C,. Oral microbial biofilm and plaque related diseases: Microbial communities and their role in the shift from oral health to disease. Clin Oral Invest 2003; 7: 181 -188.
3. Kinane DF,. Causation and pathogenesis of periodontal disease. Periodontol 2000 2001; 25: 8 -20.
4. Beagrie GS,. An autoradiography study of the gingival epithelium of mice and monkeys with thymidine-H3. Dent Prac 1963; 14: 18 -26.
5. Gottlow J, Nyman S, Lindhe J, Karring T, Wennstrom J,. New attachment formation in the human periodontium by guided tissue regeneration. J Clin Periodontol 1986; 13: 604 -616.
6. Nyman S, Lindhe J, Karring T, Rylander H,. New attachment following surgical treatment of human periodontal disease. J Clin Periodontol 1982; 9: 290 -296.
7. Karring T, Nyman S, Gottlow J, Laurell L,. Development of the biological concept of guided tissue regeneration-animal and human studies. Periodontol 2000 1993; 1: 26 -35.
8. Tempro PJ, Nalbandian J,. Colonization of retrieved polytetrafluoroethane membranes: Morphological and microbiological observations. J Periodontol 1993; 64: 162 -168.
9. Owen GR, Jackson J, Chehroudi B, Burt H, Brunette DM,. A PLGA membrane controlling cell behavior for promoting tissue regeneration. Biomaterials 2005; 26: 7447 -7456.
10. Teixeira LN, Crippa GE, Trabuco AC, Gimenes R, Zaghete MA, Palioto DB, de Oliveira PT, Rosa AL, Beloti MM,. In vitro biocompatibility of poly(vinylidene fluoride-trifluoroethylene)/barium titanate composite using cultures of human periodontal ligament fibroblasts and keratinocytes. Acta Biomater 2010; 6: 979 -989.
11. Kuo SM, Chang SJ, Chen TW, Kuan TC,. Guided tissue regeneration for using a chitosan membrane: An experimental study in rats. J Biomed Mater Res A 2006; 76: 408 -415.
12. Czaja WK, Young DJ, Kawecki M, Brown RM Jr,. The future prospects of microbial cellulose in biomedical applications. Biomacromolecules 2007; 8: 1 -12.
13. Ku Y, Shim IK, Lee JY, Park YJ, Rhee SH, Nam SH, Park JB, Chung CP, Lee SJ,. Chitosan/poly(L -lactic acid) multilayered membrane for guided tissue regeneration. J Biomed Mater Res A 2009; 90: 766 -772.
14. Borges GJ, Novaes AB Jr, de Moraes Grisi MF, Palioto DB, Taba M Jr, de Souza SL,. Acellular dermal matrix as a barrier in guided bone regeneration: A clinical, radiographic and histomorphometric study in dogs. Clin Oral Implants Res 2009; 20: 1105 -1115.
15. Yang F, Both SK, Yang X, Walboomers XF, Jansen JA,. Development of an electrospun nano-apatite/PCL composite membrane for GTR/GBR application. Acta Biomater 2009; 5: 3295 -3304.
16. Mei F, Zhong J, Yang X, Ouyang X, Zhang S, Hu X, Ma Q, Lu J, Ryu S, Deng X,. Improved biological characteristics of poly(L -lactic acid) electrospun membrane by incorporation of multiwalled carbon nanotubes/hydroxyapatite nanoparticles. Biomacromolecules 2007; 8: 3729 -3735.
17. Liao S, Watari F, Zhu Y, Uo M, Akasaka T, Wang W, Xu G, Cui F,. The degradation of the three layered nano-carbonated hydroxyapatite/collagen/PLGA composite membrane in vitro. Dent Mater 2007; 23: 1120 -1128.
18. Nieminen T, Kallela I, Keränen J, Hiidenheimo I, Kainulainen H, Wuolijoki E, Rantala I,. In vivo and in vitro degradation of a novel bioactive guided tissue regeneration membrane. Int J Oral Maxillofac Surg 2006; 35: 727 -732.
19. Kurti B, Unsal B, Cetiner D, Gültekin E, Ozcan G, Celebi N, Ocak O,. Effect of polylactide/glycolide (PLGA) membranes loaded with metronidazole on periodontal regeneration following guided tissue regeneration in dogs. J Periodontol 2002; 73: 694 -700.
20. Chen YT, Hung SL, Lin LW, Chi LY, Ling LJ,. Attachment of periodontal ligament cells to chlorhexidine-loaded guided tissue regeneration membranes. J Periodontol 2003; 74: 1652 -1659.
21. Kim IY, Jung UW, Kim CS, Lee YK, Cho KS, Chai JK, Kim CK, Choi SH,. Effects of a tetracycline blended polylactic and polyglycolic acid membrane on the healing of one-wall intrabony defects in beagle dogs. Biomed Mater 2007; 2: S106 -S110.
22. Lu L, Garcia C, Mikos AG,. In vitro degradation of thin poly(DL -lactic-co-glycolic acid) films. J Biomed Mater Res 1999; 46: 226 -244.
23. Anderson RM, Romfli RF,. Perspectives on sutures. In:, Anderson RM, Romfli RF, editors. Techniques in the Use of Surgical Tools, Chapter II. New York: Appleton-Century Croftset; 1980. p 183 -205.
24. Middleton JC, Tipton AJ,. Synthetic biodegradable polymers as medical devices. Med Plast Biomater 1998; 5: 1 -9.
25. Kranz H, Ubrich N, Maincent P, Bodmer R,. Physiochemical properties of biodegradable poly(D,L -lactide) and poly(D,L -lactide-co-glycolide) films in the dry and wet states. J Pharm Sci 2000; 89: 1558 -1566.
26. Penco M, Marconi S, Ferruti P, D'Antone S, Deghenghi R,. Degradation behavior of block copolymers containing poly(lactic-glycolic acid) and poly(ethylene glycol) segments. Biomaterials 1996; 17: 1583 -1590.
27. Rosen S,. Fundamental Principles of Polymeric Materials, 2nd ed. New York: John Wiley & Sons; 1993. p 103 -119.
28. Jackson JK, Letchford K, Babuk KA, Machan L, Signore P, Hunter WL, Wang K, Burt HM,. The characterization of poly(lactic-co-glycolic acid) films containing paclitaxel for the perivascular treatment of restenosis in rats. Int J Pharm 2004; 283: 97 -109.
29. Long KA, Jackson JK, Yang C, Chehroudi B, Brunette DM, Burt HM,. Controlled release of alendronate from polymeric films. J Biomater Sci Polym Ed 2009; 20: 653 -672.
30. Sutter VL, Jones MJ, Ghoneium ATM,. Antimicrobial susceptibility of bacteria associated with periodontal diseases. Antimicrob Agents Chemother 1983; 23: 483 -486.
31. Golub LM, Lee H-M, Ryan ME,. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998; 12: 12 -16.
32. Guggenheimer J,. Tetracycline and the human dentition. Comp Cont Ed Dent 1984; 5: 245 -254.
33. Chopra I, Roberts M,. Tetracycline antibiotics: Modes of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001; 65: 232 -260.
34. Goodson JM,. Controlled drug delivery. A new means of treatment of dental diseases. Comp Cont Ed Dent 1985; 6: 27 -36.
35. Florence AT, Attwood D,. Physiochemical Principles of Pharmacy, 4th ed. London: Pharmaceutical Press; 2005. p 161 -162.
36. Brunette DM, Melcher AH, Moe HK,. Culture and origin of epithelium-like fibroblast-like cells from porcine periodontal ligament explants and cell suspensions. Arch Oral Biol 1976; 21: 393 -400.
37. Lui H, Park GE, Webster TJ,. Biocomposites. In:, Wnek GE, Bowlin GL, editors. Encyclopedia of Biomaterials and Biomedical Engineering. New York: Informa Healthcare; 2008. p 118.
38. Lu HK, Lee SY, Lin FP,. Elastic modulus, permeation time and swelling ratio of a new porcine dermal collagen membrane. J Periodontal Res 1998; 33: 243 -248.
39. Vey E, Roger C, Meehan L, Booth J, Claybourn M, Miller AF, Saiani A,. Degradation mechanism of poly(lactic-co-glycolic) acid and block copolymer cast films in phosphate buffer solution. Polym Degrad Stab 2008; 93: 1869 -1876.
40. Aatiker E, Gümüsderelioglu M, Güner A,. Degradation of PLA, PLGA homo-and copolymers in the presence of serum albumin: A spectroscopic investigation. Polym Int 2000; 49: 728 -734.
41. Goodson JM, Haffajee A, Socransky SS,. Periodontal therapy by local delivery of tetracycline. J Clin Periodontol 1979; 6: 83 -92.
42. Vyas SP, Sihorkar V, Mishra V,. Controlled and targeted drug delivery strategies towards intraperiodontal pocket diseases. J Clin Pharm Ther 2000; 25: 21 -42.
43. Goodson JM,. Pharmokinetic principles controlling efficacy of oral therapy. J Dent Res 1989; 68: 1625 -1632.
44. Goodson JM,. Controlled drug delivery: A new means of treatment of dental diseases. Comp Cont Ed Dent 1985; 6: 27 -36.
45. Asikainen S, Saarela M, Alauusua S, Jousimies-Somer H,. In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans. Scand J Dent Res 1993; 101: 299 -303.
46. Walker CB, Pappas JD, Tyler KZ, Cohen S, Gordon JM,. Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents. J Periodontol 1985; 56: 67 -74.
47. Walker CB,. Antimicrobial agents and chemotherapy. In:, Slots J, Taubmann M, editors. Contemporay Oral Microbiology and Immunology. St Louis: Mosby Yearbook; 1992. p 242 -264.
48. Slots J, Rams TE,. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990; 17: 479 -493.
49. Walker CB, Gordon JM, Magnusson I, Clark WB,. A role for antibiotics in the treatment of refractory periodontitis. J Periodontol 1993; 64: 772 -781.
50. Rams TE, Slots J,. Local delivery of mantimicrobial agents in the periodontal pocket. Periodontol 2000 1996; 10: 139 -159.
51. Golub LM, Goodson JM, Lee HM, Vidal AM, McNamara TF, Ramamurthy NS,. Tetracyclines inhibit tissue collagenases. Effects of ingested low-dose and local delivery systems. J Periodontol 1985; 56: 93 -97.
52. Baker PJ, Evans RT, Coburn RA, Genco RJ,. Tetracycline and its derivatives strongly bind to and are released from the tooth surface in active form. J Periodontol 1983; 54: 580 -585.
53. Wikesjö UME, Baker PJ, Christersson LA, Genco RJ, Lyall RM, Hic S, DiFlorio RM, Terranova VP,. A biochemical approach to periodontal regeneration: Tetracycline treatment conditions dentin surfaces. J Periodont Res 1986; 21: 322 -329.
54. Tonetti M, Cugini M, Goodson J,. Zero-order delivery with periodontal placement of tetracycline loaded ethylene vinyl acetate fibers. J Periodont Res 1990; 25: 243 -249.
55. Ciancio S, Cobb C, Leung M,. Tissue concentration and localization of tetracycline flowing site specific tetracycline fiber therapy. J Periodontol 1992; 63: 849 -853.
56. Lamont RJ, Oda D, Persson RE, Persson GR,. Interaction of porphyromonas gingivalis with gingival epithelial cells maintained in culture. Oral Microbiol Immunol 1992; 7: 364 -367.
57. Duncan MJ, Nakao S, Skobe Z, Xie H,. Interactions of porphyromonas gingivalis with epithelial cells. Infect Immun 1993; 61: 2260 -2265.
58. Sandros J, Papapanou P, Dahlen G,. Porphyromonas gingivalis invades oral epithelial cells in vitro. J Periodont Res 1993; 28: 219 -226.
59. Kato S, Nakashima K, Inoue M, Tomioka J, Nonaka K, Nishihara T, Kowashi Y,. Human epithelial cell death caused by Actinobacillus actinomycetemcomitans infection. J Med Microbiol 2000; 49: 739 -745.
60. Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S,. The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol 1998; 69: 1085 -1091.
61. Rapley J, Cobb C, Leung M,. Serum levels of tetracycline during treatment with tetracycline containing fibers. J Periodontol 1992; 63: 817 -820.
62. Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS,. Tetracyline: Levels achievable in gingival crevice fluid and the in vitro effect on subgingival organisms. I. Concentration in crevicular fluid after repeated doses. J Periodontol 1981; 52: 609 -612.
63. Burns FR, Stack MS, Gray RD, Paterson CA,. Inhibition of purified collagenase from alkaline-burned rabbit corneas. Invest Opthalmol Vis Sci 1989; 30: 1569 -1575.
64. Rifkin BR, Vernillo AT, Golub LM,. Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: A potential therapeutic role for tetracyclines and their chemically modified analogs. J Periodontol 1993; 64: 819 -827.
65. M M, Söderling E, Pauino K, Talonpoika J, Hyyppä T,. Protein composition of crevicular fluid before and after treatment. Scand J Dent Res 1991; 99: 413 -423.
66. Curtis MA, Sterne JAC, Price SJ, Griffiths GS, Coulthurst SK, Wilton JMA, Johnson NW,. The protein composition of gingival crevicular fluid sampled from male adolescents with no destructive periodontitis: Baseline data of a longitudinal study. J Periodont Res 1990; 25: 6 -16.
67. Aatiker E, Gümüsderelioglu M, Güner A,. Degradation of PLA, PLGA homo-and copolymers in the presence of serum albumin: A spectroscopic investigation. Polym Int 2000; 49: 728 -734.